Gradient Capital Advisors »

Regeneron Pharmaceuticals shares owned by Gradient Capital Advisors

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Gradient Capital Advisors from 13F filings

Historical chart of Gradient Capital Advisors investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Gradient Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Gradient Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $404k 384 1051.24
2024-06-30 $404k 384 1051.03
2024-03-31 $370k 384 962.49
2023-12-31 $337k 384 878.29
2023-09-30 $316k 384 822.96
2023-06-30 $276k 384 718.54
2023-03-31 $316k 384 821.67
2022-12-31 $277k 384 721.49
2022-09-30 $265k 384 690.10